Kepler Capital Keeps Their Buy Rating on Siemens Healthineers AG (SEMHF)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 13 2025
0mins
Source: Business Insider
Analyst Ratings: Oliver Reinberg from Kepler Capital maintains a Buy rating on Siemens Healthineers AG with a price target of €65.00, while Deutsche Bank also issued a Buy rating, and UBS has a Hold rating on the stock.
Financial Performance: Siemens Healthineers reported a quarterly revenue of $6.33 billion and a net profit of $616 million for Q1 2025, showing growth compared to the previous year, alongside positive insider sentiment regarding the stock.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
